Statera Biopharma, Inc. Quarterly Contract with Customer, Liability, Current in USD from Q3 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary
Statera Biopharma, Inc. quarterly Contract with Customer, Liability, Current history and growth rate from Q3 2020 to Q3 2022.
  • Statera Biopharma, Inc. Contract with Customer, Liability, Current for the quarter ending September 30, 2022 was $387K, a 23.5% decline year-over-year.
Contract with Customer, Liability, Current, Quarterly (USD)
Contract with Customer, Liability, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $387K -$119K -23.5% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $550K Jun 30, 2022 10-Q 2022-10-28
Q1 2022 $206K Mar 31, 2022 10-Q 2022-10-21
Q4 2021 $373K +$373K Dec 31, 2021 10-Q 2022-11-14
Q3 2021 $506K +$499K +7314% Sep 30, 2021 10-Q 2021-11-15
Q4 2020 $0 Dec 31, 2020 10-K 2022-10-06
Q3 2020 $6.83K Sep 30, 2020 10-Q 2020-11-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.